Emerging Infectious Diseases (Jan 2021)

Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG

  • Sina Schwarzkopf,
  • Adalbert Krawczyk,
  • Dietmar Knop,
  • Hannes Klump,
  • Andreas Heinold,
  • Falko M. Heinemann,
  • Laura Thümmler,
  • Christian Temme,
  • Marianne Breyer,
  • Oliver Witzke,
  • Ulf Dittmer,
  • Veronika Lenz,
  • Peter A. Horn,
  • Monika Lindemann

DOI
https://doi.org/10.3201/eid2701.203772
Journal volume & issue
Vol. 27, no. 1
pp. 122 – 129

Abstract

Read online

We investigated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who had PCR-confirmed SARS-CoV-2 infection. Sixty days after onset of symptoms, 13/78 (17%) study participants had borderline or negative results to an ELISA detecting IgG against the S1 protein of SARS-CoV-2. We analyzed participants with PCR-confirmed infection who had strong antibody responses (ratio >3) as positive controls and participants without symptoms of SARS-CoV-2 infection and without household contact with infected patients as negative controls. Using interferon-γ ELISpot, we observed that 78% of PCR-positive volunteers with undetectable antibodies showed T cell immunity against SARS-CoV-2. We observed a similar frequency (80%) of T-cell immunity in convalescent donors with strong antibody responses but did not detect immunity in negative controls. We concluded that, in convalescent patients with undetectable SARS-CoV-2 IgG, immunity may be mediated through T cells.

Keywords